OTCBB:ENDV

Endonovo Therapeutics Stock Insider Trading

etoro logo Buy ENDV
*Your capital is at risk
$0.0001
+0 (+0%)
At Close: Jul 31, 2026

Endonovo Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 176.6K and sold 0 ENDV shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 176.6K shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Dec 02, 2019
Buy
Common Stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 2 000
Value: $6
Dec 02, 2019
Buy
Common Stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 2 000
Value: $6
Nov 29, 2019
Buy
Common Stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 2 000
Value: $6
Nov 29, 2019
Buy
Common Stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 2 000
Value: $6
Nov 27, 2019
Buy
Common Stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 2 000
Value: $7
Nov 27, 2019
Buy
Common Stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 1 000
Value: $4
Nov 27, 2019
Buy
Common Stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 1 000
Value: $4
Nov 27, 2019
Buy
Common Stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 2 000
Value: $7
Nov 25, 2019
Buy
Common Stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 2 000
Value: $7
Nov 25, 2019
Buy
Common Stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 2 000
Value: $7
Nov 22, 2019
Buy
Common Stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 1 000
Value: $4
Nov 22, 2019
Buy
Common Stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 1 000
Value: $4
Nov 22, 2019
Buy
Common Stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 1 000
Value: $4
Nov 22, 2019
Buy
Common Stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 1 000
Value: $4
Nov 20, 2019
Buy
Common Stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 1 000
Value: $4
Nov 20, 2019
Buy
Common Stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 1 000
Value: $4
Nov 11, 2019
Buy
Common stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 2 000
Value: $14
Nov 11, 2019
Buy
Common stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 2 000
Value: $14
Nov 04, 2019
Buy
Common Stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 10 000
Value: $58
Nov 04, 2019
Buy
Common Stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 5 000
Value: $30
Nov 04, 2019
Buy
Common Stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 5 000
Value: $30
Nov 04, 2019
Buy
Common Stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 10 000
Value: $58
Oct 31, 2019
Buy
Common Stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 5 000
Value: $30
Oct 31, 2019
Buy
Common Stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 5 000
Value: $25
Oct 31, 2019
Buy
Common Stock
P-Purchase
Collier Alan Brian
CEO
CEO / President 5 000
Value: $25

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ENDONOVO THERAPEUTICS, INC.
Endonovo Therapeutics
Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of inflammation, wounds, cardiova...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE